Asclepion Launches Upgrades for its MeDioStar Hair Removal Lasers in the United States Through Its Partner U.S. Medical

MeDioStar Upgrades and New MeDioStar Hand-Piece to be Marketed by Partner U.S. Medical, Inc.


JENA, Germany, Dec. 20, 2001 (PRIMEZONE) -- Asclepion-Meditec AG (Securities code number 531 370) (GER:AFX), through its partnership with U.S. Medical, announces two enhancements to its line of Aesthetic lasers for sale in the United States.

Since the market introduction back in June 2000, Asclepion-Meditec AG was able to successfully sell its hair removal high power diode laser MeDioStar HC through U.S. Medical in the United States. With the later addition of the new economic model MeDioStar C, both companies were able to target a broader range of physicians.

Today, Asclepion launches its professional software upgrades and one application upgrade which consists of a new 6mm hand-piece for vascular lesions for the MeDioStar lasers in the United States. These upgrades are ideal supplements to both, the MeDioStar HC and C and offer the user a highest measure of comfort for laser assisted treatments. These upgrades feature the so-called "professional mode." Pulse length, pulse pause and fluency can be adjusted completely independently. This way, the experienced user can adapt the treatment even more individually to the patients' hair and skin type. The new 6mm hand-piece and the professional software upgrades for the MeDioStar allow the physician a broader range of revenue generating possibilities to add to their aesthetic practices without adding another system.

The market launch of these innovative Asclepion additions in the United States through U.S. Medical will strengthen the cooperations between Asclepion and U.S. Medical. Through the availability of the new hand-piece and the professional upgrades, both companies will improve their market position in the United States.

The addition of these new and exciting opportunities to the current wide range of Asclepion products offered by U.S. Medical is believed to be, just what the doctor needs.

Asclepion-Meditec AG (Securities Id. No.: 531 370, symbol: AFX, www.asclepion.com), with subsidiaries in the United Kingdom, Italy and the USA, is one of the global technology and innovation leaders of laser medicine.

Asclepion launched the world's first excimer laser for refractive surgery in 1986. Other world firsts include the YAG laser for photo disruption (1981) and the erbium dental laser (1991).

The company is the largest European manufacturer of laser systems for ophthalmology (vision correction and eye disease), dermatology (aesthetic applications like laser hair removal or tattoo removal) and dentistry (virtually pain-free caries treatment). Furthermore the company has an extensive worldwide service network.

U.S.Medical, Inc.

Founded in June 1996, U.S. Medical, Inc. is the most rapidly growing distributor of new and previously owned capital medical equipment (CME) to the health care practitioner industry in the United States. The Company actively sells thousands of types of CME products to thousands of medical practitioners throughout North America, and is planning to expand its distribution into Europe and Latin America. U.S. Medical, Inc. is the first CME distributor to receive ISO 9002 certification from the International Organization of Standards and is also the largest CME distributor to become fully e-commerce-enabled via its website: www.USMedical.com.



            

Contact Data